Company
Belluscura plc
Headquarters: London, United Kingdom
Employees: 6
CEO: Mr. Robert Rauker
Belluscura plc Categories
United Kingdom Healthcare Medical DevicesUnited Kingdom Healthcare United Kingdom Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | June 30, 2023 |
| Revenue TTM | £958,438 |
| EBITDA | £-6,233,422 |
| Gross Profit TTM | £68,105 |
| Profit Margin | 4.87% |
| Operating Margin | -1090.44% |
| Quarterly Revenue Growth | -34.80% |
Stocks & Indices
Belluscura plc has the following listings and related stock indices.
Stock: LSE: BELL wb_incandescent
Stock: FSX: 9VQ wb_incandescent